Enlivex Therapeutics Ltd. (ENLV.TA)
ILA 433.2
(5.2%)
ILA 433.2
(5.2%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.56 USD | 7.69% |
| 2022 | -1.69 USD | -108.64% |
| 2021 | -0.81 USD | 10.0% |
| 2020 | -0.90 USD | 16.67% |
| 2019 | -1.08 USD | 10.74% |
| 2018 | -1.21 USD | 91.57% |
| 2017 | -14.35 USD | 64.38% |
| 2016 | -40.29 USD | 6.71% |
| 2015 | -43.19 USD | -88.52% |
| 2014 | -22.91 USD | -444.18% |
| 2013 | -4.21 USD | -401.19% |
| 2012 | -0.84 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.22 USD | 55.1% |
| 2024 Q2 | -0.16 USD | 27.27% |
| 2023 Q2 | -0.37 USD | 5.13% |
| 2023 Q1 | -0.39 USD | 0.0% |
| 2023 Q3 | -0.32 USD | 13.51% |
| 2023 Q4 | -0.49 USD | -53.12% |
| 2023 FY | - USD | 7.69% |
| 2022 Q2 | -0.54 USD | -20.0% |
| 2022 Q3 | -0.31 USD | 42.59% |
| 2022 Q4 | -0.39 USD | -25.81% |
| 2022 FY | - USD | -108.64% |
| 2022 Q1 | -0.45 USD | -66.67% |
| 2021 Q4 | -0.27 USD | -42.11% |
| 2021 FY | - USD | 10.0% |
| 2021 Q3 | -0.19 USD | -11.76% |
| 2021 Q2 | -0.17 USD | 10.53% |
| 2021 Q1 | -0.19 USD | 57.78% |
| 2020 Q1 | -0.07 USD | 99.97% |
| 2020 Q4 | -0.45 USD | -181.25% |
| 2020 Q3 | -0.16 USD | 30.43% |
| 2020 FY | - USD | 16.67% |
| 2020 Q2 | -0.23 USD | -229.99% |
| 2019 Q2 | -1.16 USD | 78.95% |
| 2019 FY | - USD | 10.74% |
| 2019 Q4 | -278.30 USD | -120900.0% |
| 2019 Q3 | -0.23 USD | 80.17% |
| 2019 Q1 | -5.51 USD | 98.79% |
| 2018 Q4 | -454.15 USD | -17993.63% |
| 2018 FY | - USD | 91.57% |
| 2018 Q1 | -2.34 USD | -75.94% |
| 2018 Q2 | -1.21 USD | 48.29% |
| 2018 Q3 | -2.51 USD | -107.44% |
| 2017 Q2 | -3.97 USD | 39.11% |
| 2017 Q1 | -6.52 USD | 13.07% |
| 2017 FY | - USD | 64.38% |
| 2017 Q4 | -1.33 USD | 48.05% |
| 2017 Q3 | -2.56 USD | 35.52% |
| 2016 Q1 | -12.70 USD | 6.41% |
| 2016 Q4 | -7.50 USD | 34.21% |
| 2016 Q3 | -11.40 USD | -26.81% |
| 2016 Q2 | -8.99 USD | 29.21% |
| 2016 FY | - USD | 6.71% |
| 2015 Q3 | -9.98 USD | 3.67% |
| 2015 Q2 | -10.36 USD | -11.76% |
| 2015 Q4 | -13.57 USD | -35.97% |
| 2015 Q1 | -9.27 USD | -4.63% |
| 2015 FY | - USD | -88.52% |
| 2014 Q3 | -6.50 USD | -109.68% |
| 2014 Q4 | -8.86 USD | -36.31% |
| 2014 Q1 | -2.34 USD | 0.0% |
| 2014 Q2 | -3.10 USD | -32.48% |
| 2014 FY | - USD | -444.18% |
| 2013 Q3 | -0.91 USD | -26.39% |
| 2013 FY | - USD | -401.19% |
| 2013 Q2 | -0.72 USD | 0.0% |
| 2013 Q4 | - USD | 100.0% |
| 2012 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Matricelf Ltd | -0.95 ILA | -64.211% |